You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 1, July 7, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Lipids and Lipid Disorders
 •Randomized Controlled Trial
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma

Since this article does not have an abstract, we have provided the first 142 words of the full text and any section headings.

To the Editor: Dr Nissen and colleagues1 reported that 80 mg of atorvastatin lowered LDL cholesterol to a greater degree than did 40 mg of pravastatin. I am concerned, however, that the study does not establish the rate of decrease over time. Although cholesterol was apparently measured every 3 months, the authors presented data only for baseline and 18 months. Similarly, the authors did not justify their use of linear regression analysis, which assumes a linear change over time. I am not convinced that that assumption is warranted in this case. It is possible, for instance, that pravastatin actually reduced LDL cholesterol to a greater degree early on in treatment.The time course would have implications for treatment. Perhaps it would be rational to begin with a faster-acting drug and then switch to a drug that is more potent in the long run.

Kavitha Rajaram, MD
kr371@med.nyu.edu
New York University
New York, NY

1. Nissen SE, Tuzcu EM, Schoenhagen P, et al, for the REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004;291:1071-1080. FREE FULL TEXT

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;292:39.


RELATED ARTICLES

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Uffe Ravnskov and Morley C. Sutter
JAMA. 2004;292(1):38.
EXTRACT | FULL TEXT  

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Paul J. Rosch
JAMA. 2004;292(1):38-39.
EXTRACT | FULL TEXT  

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Pim van der Harst, Wiek H. van Gilst, and Felix Zijlstra
JAMA. 2004;292(1):39.
EXTRACT | FULL TEXT  

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma—Reply
Steven Nissen and For the REVERSAL Investigators
JAMA. 2004;292(1):39-40.
EXTRACT | FULL TEXT  

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis: A Randomized Controlled Trial
Steven E. Nissen, E. Murat Tuzcu, Paul Schoenhagen, B. Greg Brown, Peter Ganz, Robert A. Vogel, Tim Crowe, Gail Howard, Christopher J. Cooper, Bruce Brodie, Cindy L. Grines, and Anthony N. DeMaria
JAMA. 2004;291(9):1071-1080.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.